P-71 KRYSTAL-10: A randomized phase 3 study of adagrasib (MRTX849) in combination with cetuximab vs chemotherapy in patients with previously treated advanced colorectal cancer with KRASG12C mutation
暂无分享,去创建一个
J. Tabernero | R. Yaeger | S. Kopetz | J. Bendell | J. Lee | R. Corcoran | T. Kheoh | M. Davis | A. Chi | Ryan B. Corcoran | Johanna C. Bendell | J. Christensen | Rona Yaeger